| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |